page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
|
33Cinven is a leading European buyout firm, founded in 1977, with offices in London, Paris, Frankfurt, Milan and Hong Kong. It acquires European-based companies that require an equity investment of ?100 million or more. Its European focus and expertise are complemented by an ability to capitalise on global growth opportunities through its Asian office. It focuses on six sectors: Healthcare, Business Services, Consumer, Financial Services, Industrials and Technology, Media and Telecommunications (TMT). Cinven acquires successful, high-quality companies and works with them to help them grow and develop, using its proven value creation strategies. Typically, Cinven holds its investments for between four to six years. It takes a responsible approach towards its portfolio companies, their employees, suppliers and local communities, the environment and society as a whole.The Committee's duties include determining and agreeing with the Board the policy for the remuneration of the executive directors. The policy is to ensure that members of the Executive Group are offered appropriate incentives to encourage enhanced performance and are fairly rewarded for their contributions to the success of the company. The Committee also considers other elements of Executive Group remuneration, including performance-related bonuses and equity allocation schemes.
34Spire Healthcare Annual Review 2010Chief Financial Officer's statementSpire Healthcare produced another year of strong revenue and profit growth with total revenue of £643 million, an increase of 3.7% over 2009. ""
|